@FierceBiotech: FDA finds mystery 'deficiencies' with Neos' long-acting Ritalin on the eve of approval. Story | Follow @FierceBiotech
@JohnCFierce: Anthony Philippakis at The Broad will be on my JP Morgan Big Data panel. Any other recommendations for Drug Development and Big Data: 2025? | Follow @JohnCFierce
> Congress decided to let the FDA hand out priority review vouchers as a reward for innovation in rare pediatric diseases. But some critics tell the Wall Street Journal that while these vouchers may be worth a lot, the program hasn't had the intended effect. Story
> Biotech backer Naia Limited raised $5.3 million to fund subsidiaries working on treatments for metabolic diseases. More
> The FDA has requested more information about Zogenix's ($ZGNX) proposed Phase III trial for an epilepsy treatment, but the company still plans to launch the study in the fourth quarter of this year. Item
Medical Device News
@FierceMedDev: Check out this year's Fierce 15: The new strategic med tech mania sets the stage for 2015's Fierce 15. Feature | Follow @FierceMedDev
@VarunSaxena2: Fierce 15 co. Shockwave Medical aims to deploy energy-delivering balloons in the peripheral and coronary arteries. More | Follow @VarunSaxena2
@EmilyWFierce: ICYMI yesterday: Lightpoint Medical nabs EU approval for cancer molecular imaging device. Article | Follow @EmilyWFierce
> Stryker scores point in patent battle with Zimmer. More
> Philips spins Axsun back out of Volcano, sells it to venture firm. Story
Pharma News
@FiercePharma: Japanese drugmakers Eisai, Ajinomoto team up on gastrointestinal diseases. FiercePharmaAsia story | Follow @FiercePharma
@EricPFierce: Regeneron more than doubles investment in plant in Ireland, adding 200 more workers. Report | Follow @EricPFierce
@CarlyHFierce: ICYMI: Merck KGaA exits 'sea of sameness' with futuristic rebrand. More | Follow @CarlyHFierce
> Cipla runs into FDA concerns for plant in India, as well as one it will buy in U.S. News
> Vocal pricing critic Clinton rakes in big campaign dollars from Big Pharma. Article
Drug Delivery News
> Computer models demonstrate stronger liposomal shells for drug delivery. More
> Researchers deploy malarial protein as targeting agent for anticancer drugs. Report
> Ear drug delivery to get a boost from launch of hearing loss therapeutics company Decibel. Item
> Alnylam reveals molecule to reverse effect of its RNAi therapies. Story
> Novo to expand use of Emisphere's oral delivery platform in deal potentially worth $80M+. Article
Pharma Manufacturing News
> FDA cites Cipla India plant after U.S. recall of asthma drug. News
> Recipharm shelling out $105M for Indian sterile injectables CMO. Report
> Hovione adding a formulation plant in Portugal. More
> TxCell, whose plant was closed for mold issues, intends to use CMOs exclusively. Story
> Regeneron doubles down on plant project in Ireland. Article
Pharma Asia News
> Indian drug manufacturers face higher costs with bar-code requirement. Report
> NY-based Athenex has big China manufacturing plans with name change to boot. Story
> Japan's Daiichi Sankyo to cut as many as 1,200 U.S. jobs in reorganization. Item
> Vietnam's Vinamilk on the block--will Abbott bite? More
> HK-based Chi-Med looks to tap funds in Nasdaq listing with China focus. Article